Overview

Study of Mirogabalin for Central Neuropathic Pain

Status:
Completed
Trial end date:
2020-12-28
Target enrollment:
Participant gender:
Summary
Investigate the efficacy and safety of mirogabalin in participants with central neuropathic pain in comparison to placebo
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Co., Ltd.